Pedrinelli R, Spessot M, Salvetti A
Hypertension Unit, University of Pisa, Italy.
J Hypertens. 1990 May;8(5):467-71. doi: 10.1097/00004872-199005000-00012.
The aim of the present study was to further validate our method for the determination of minimal forearm vascular resistance after ischemia (13 min arterial occlusion and 1 min hand exercise) in patients with hypertension. This parameter, calculated as the ratio of mean blood pressure (intra-arterial recordings on the experimental side) to forearm blood flow (strain-gauge venous plethysmography), was measured basally and after either increasing (through unrelated vasodilators such as sodium nitroprusside or the calcium antagonist nicardipine in six mild-to-moderate uncomplicated hypertensives) or decreasing (norepinephrine, n = 4) flow without changes in systemic pressure. In spite of the divergent starting flow values, minimal postischemic forearm vascular resistance was unchanged, indicating a lack of relationship with functional arteriolar tone and the achievement of maximal dilatation. In two additional groups of patients, systemic arterial pressure was decreased by approximately equipotent oral doses of either nifedipine, a calcium antagonist (n = 6), or captopril, an angiotension converting enzyme inhibitor (n = 5). Under these conditions, minimal forearm vascular resistance was unchanged from pretreatment values, suggesting that local autoregulatory mechanisms were overridden during the reactive hyperemia, and that the vessel lumen was dependent on the distending pressure. Overall, the data show that our experimental conditions are suitable for measuring minimal forearm vascular resistance as a functional correlate of the morphological status of systemic arterioles in arterial hypertension.
本研究的目的是进一步验证我们用于测定高血压患者缺血后(动脉闭塞13分钟和手部运动1分钟)前臂最小血管阻力的方法。该参数通过平均血压(实验侧动脉内记录)与前臂血流量(应变片静脉体积描记法)的比值计算得出,在基础状态下以及在不改变全身压力的情况下增加(通过无关的血管扩张剂,如硝普钠或钙拮抗剂尼卡地平,用于6例轻度至中度无并发症高血压患者)或减少(去甲肾上腺素,n = 4)血流量后进行测量。尽管起始血流量值不同,但缺血后前臂最小血管阻力未发生变化,表明其与功能性小动脉张力无关且已达到最大扩张。在另外两组患者中,通过口服等效剂量的钙拮抗剂硝苯地平(n = 6)或血管紧张素转换酶抑制剂卡托普利(n = 5)使全身动脉压降低。在这些条件下,前臂最小血管阻力与治疗前值相比未发生变化,这表明在反应性充血期间局部自动调节机制被超越,并且血管腔取决于扩张压力。总体而言,数据表明我们的实验条件适合测量前臂最小血管阻力,作为动脉高血压患者全身小动脉形态状态的功能相关指标。